<産業資料/調査レポートの題名> 2022年4月19日

ビリルビン血液検査の世界市場2020-2024


◆英文タイトル:Global Bilirubin Blood Test Market 2020-2024

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Value chain analysis
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2019
• Market size and forecast 2019-2024
• Market outlook
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• Infants – Market size and forecast 2019-2024
• Adults – Market size and forecast 2019-2024
• Market opportunity by type
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2019-2024
• Europe – Market size and forecast 2019-2024
• Asia – Market size and forecast 2019-2024
• ROW – Market size and forecast 2019-2024
• Key leading countries
• Market opportunity
PART 09: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 10: MARKET TRENDS
• Growing number of strategic alliances
• Increasing demand for non-invasive procedures
• Government initiatives and funding for bilirubin testing
PART 11: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 12: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott Laboratories
• Danaher Corp.
• Drägerwerk AG & Co. KGaA
• F. Hoffmann-La Roche Ltd.
• Koninklijke Philips NV
• Merck KGaA
• Randox Laboratories Ltd.
• Reichert Inc.
• Siemens Healthineers AG
• Thermo Fisher Scientific Inc.
PART 13: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 14: EXPLORE TECHNAVIO


Exhibit 01: Global healthcare supplies market
Exhibit 02: Segments of global healthcare supplies market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Product overview
Exhibit 06: Market definition – Inclusions and exclusions checklist
Exhibit 07: Market size 2019
Exhibit 08: Global market: Size and forecast 2019-2024 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2020-2024 (%)
Exhibit 10: Five forces analysis 2019
Exhibit 11: Five forces analysis 2024
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition – Five forces 2019
Exhibit 18: Type – Market share 2019-2024 (%)
Exhibit 19: Comparison by type
Exhibit 20: Infants – Market size and forecast 2019-2024 ($ millions)
Exhibit 21: Infants – Year-over-year growth 2020-2024 (%)
Exhibit 22: Adults – Market size and forecast 2019-2024 ($ millions)
Exhibit 23: Adults – Year-over-year growth 2020-2024 (%)
Exhibit 24: Market opportunity by type
Exhibit 25: Customer landscape
Exhibit 26: Market share by geography 2019-2024 (%)
Exhibit 27: Geographic comparison
Exhibit 28: North America – Market size and forecast 2019-2024 ($ millions)
Exhibit 29: North America – Year-over-year growth 2020-2024 (%)
Exhibit 30: Europe – Market size and forecast 2019-2024 ($ millions)
Exhibit 31: Europe – Year-over-year growth 2020-2024 (%)
Exhibit 32: Asia – Market size and forecast 2019-2024 ($ millions)
Exhibit 33: Asia – Year-over-year growth 2020-2024 (%)
Exhibit 34: ROW – Market size and forecast 2019-2024 ($ millions)
Exhibit 35: ROW – Year-over-year growth 2020-2024 (%)
Exhibit 36: Key leading countries
Exhibit 37: Market opportunity
Exhibit 38: Product launch details
Exhibit 39: Number of preterm births/LBW infants per 100 live births, 2014
Exhibit 40: Product recalls: Overview
Exhibit 41: Impact of drivers and challenges
Exhibit 42: Business strategies
Exhibit 43: Vendor landscape
Exhibit 44: Landscape disruption
Exhibit 45: Vendors covered
Exhibit 46: Vendor classification
Exhibit 47: Market positioning of vendors
Exhibit 48: Abbott Laboratories – Vendor overview
Exhibit 49: Abbott Laboratories – Business segments
Exhibit 50: Abbott Laboratories – Organizational developments
Exhibit 51: Abbott Laboratories – Geographic focus
Exhibit 52: Abbott Laboratories – Segment focus
Exhibit 53: Abbott Laboratories – Key offerings
Exhibit 54: Abbott Laboratories – Key customers
Exhibit 55: Danaher Corp. – Vendor overview
Exhibit 56: Danaher Corp. – Business segments
Exhibit 57: Danaher Corp. – Organizational developments
Exhibit 58: Danaher Corp. – Geographic focus
Exhibit 59: Danaher Corp. – Segment focus
Exhibit 60: Danaher Corp. – Key offerings
Exhibit 61: Danaher Corp. – Key customers
Exhibit 62: Drägerwerk AG & Co. KGaA – Vendor overview
Exhibit 63: Drägerwerk AG & Co. KGaA – Organizational developments
Exhibit 64: Drägerwerk AG & Co. KGaA – Geographic focus
Exhibit 65: Drägerwerk AG & Co. KGaA – Key offerings
Exhibit 66: Drägerwerk AG & Co. KGaA – Key customers
Exhibit 67: F. Hoffmann-La Roche Ltd. – Vendor overview
Exhibit 68: F. Hoffmann-La Roche Ltd. – Business segments
Exhibit 69: F. Hoffmann-La Roche Ltd. – Organizational developments
Exhibit 70: F. Hoffmann-La Roche Ltd. – Geographic focus
Exhibit 71: F. Hoffmann-La Roche Ltd. – Segment focus
Exhibit 72: F. Hoffmann-La Roche Ltd. – Key offerings
Exhibit 73: F. Hoffmann-La Roche Ltd. – Key customers
Exhibit 74: Koninklijke Philips NV – Vendor overview
Exhibit 75: Koninklijke Philips NV – Business segments
Exhibit 76: Koninklijke Philips NV – Organizational developments
Exhibit 77: Koninklijke Philips NV – Geographic focus
Exhibit 78: Koninklijke Philips NV – Segment focus
Exhibit 79: Koninklijke Philips NV – Key offerings
Exhibit 80: Koninklijke Philips NV – Key customers
Exhibit 81: Merck KGaA – Vendor overview
Exhibit 82: Merck KGaA – Business segments
Exhibit 83: Merck KGaA – Organizational developments
Exhibit 84: Merck KGaA – Geographic focus
Exhibit 85: Merck KGaA – Segment focus
Exhibit 86: Merck KGaA – Key offerings
Exhibit 87: Merck KGaA – Key customers
Exhibit 88: Randox Laboratories Ltd. – Vendor overview
Exhibit 89: Randox Laboratories Ltd. – Business segments
Exhibit 90: Randox Laboratories Ltd. – Key offerings
Exhibit 91: Randox Laboratories Ltd. – Key customers
Exhibit 92: Reichert Inc. – Vendor overview
Exhibit 93: Reichert Inc. – Business segments
Exhibit 94: Reichert Inc. – Key offerings
Exhibit 95: Reichert Inc. – Key customers
Exhibit 96: Siemens Healthineers AG – Vendor overview
Exhibit 97: Siemens Healthineers AG – Business segments
Exhibit 98: Siemens Healthineers AG – Organizational developments
Exhibit 99: Siemens Healthineers AG – Geographic focus
Exhibit 100: Siemens Healthineers AG – Segment focus
Exhibit 101: Siemens Healthineers AG – Key offerings
Exhibit 102: Siemens Healthineers AG – Key customers
Exhibit 103: Thermo Fisher Scientific Inc. – Vendor overview
Exhibit 104: Thermo Fisher Scientific Inc. – Business segments
Exhibit 105: Thermo Fisher Scientific Inc. – Organizational developments
Exhibit 106: Thermo Fisher Scientific Inc. – Geographic focus
Exhibit 107: Thermo Fisher Scientific Inc. – Segment focus
Exhibit 108: Thermo Fisher Scientific Inc. – Key offerings
Exhibit 109: Thermo Fisher Scientific Inc. – Key customers
Exhibit 110: Validation techniques employed for market sizing
Exhibit 111: Definition of market positioning of vendors


LINEで送る
Share on LinkedIn
このエントリーをはてなブックマークに追加
Bookmark this on BuzzURL
Bookmark this on Yahoo Bookmark